MEI Pharma Price Patterns
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
Momentum 56
Buy Extended
Oversold | Overbought |
Using MEI Pharma hype-based prediction, you can estimate the value of MEI Pharma from the perspective of MEI Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MEI Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying MEI because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MEI Pharma after-hype prediction price | USD 3.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
MEI |
MEI Pharma After-Hype Price Density Analysis
As far as predicting the price of MEI Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MEI Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MEI Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MEI Pharma Estimiated After-Hype Price Volatility
In the context of predicting MEI Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MEI Pharma's historical news coverage. MEI Pharma's after-hype downside and upside margins for the prediction period are 3.07 and 3.07, respectively. We have considered MEI Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MEI Pharma is very steady at this time. Analysis and calculation of next after-hype price of MEI Pharma is based on 3 months time horizon.
MEI Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as MEI Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEI Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MEI Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 10 Events / Month | 4 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.07 | 3.07 | 0.00 |
|
MEI Pharma Hype Timeline
MEI Pharma is now traded for 3.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. MEI is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on MEI Pharma is about 0.0%, with the expected price after the next announcement by competition of 3.07. The company recorded a loss per share of 4.75. MEI Pharma last dividend was issued on the 16th of November 2023. The entity had 1:20 split on the 17th of April 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.MEI Pharma Related Hype Analysis
Having access to credible news sources related to MEI Pharma's direct competition is more important than ever and may enhance your ability to predict MEI Pharma's future price movements. Getting to know how MEI Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MEI Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MTVA | MetaVia | (0.08) | 10 per month | 0.00 | (0.15) | 11.60 | (20.10) | 79.95 | |
| TRAW | Traws Pharma | (0.06) | 10 per month | 8.83 | 0.02 | 17.70 | (12.90) | 58.96 | |
| ELEV | Elevation Oncology | 0.00 | 6 per month | 3.35 | 0.05 | 9.09 | (6.67) | 29.95 | |
| PHXM | PHAXIAM Therapeutics SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PIRS | Pieris Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DOMH | Dominari Holdings | 0.1 | 3 per month | 0.00 | (0.09) | 5.71 | (8.39) | 24.67 | |
| KA | Kineta Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NYMXF | Nymox Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.02) | 36.54 | (23.42) | 68.44 | |
| CSCI | COSCIENS Biopharma | (0.04) | 5 per month | 10.84 | 0.04 | 36.74 | (28.04) | 94.83 | |
| LSB | LakeShore Biopharma Co | (0.06) | 4 per month | 8.14 | 0.02 | 12.33 | (12.50) | 91.99 |
MEI Pharma Additional Predictive Modules
Most predictive techniques to examine MEI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MEI using various technical indicators. When you analyze MEI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MEI Pharma Predictive Indicators
The successful prediction of MEI Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MEI Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MEI Pharma based on analysis of MEI Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MEI Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MEI Pharma's related companies.
Pair Trading with MEI Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with MEI Stock
| 0.62 | PPERY | Bank Mandiri Persero Earnings Call This Week | PairCorr |
| 0.62 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against MEI Stock
| 0.69 | PG | Procter Gamble | PairCorr |
| 0.6 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.58 | BKRKY | Bank Rakyat | PairCorr |
| 0.47 | MSFT | Microsoft | PairCorr |
| 0.44 | PBCRF | PT Bank Central | PairCorr |
| 0.42 | PBCRY | Bank Central Asia | PairCorr |
The ability to find closely correlated positions to MEI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEI Pharma to buy it.
The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in MEI Stock
If you are still planning to invest in MEI Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEI Pharma's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |